These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8429239)

  • 1. Detection of the 170-kDa bullous pemphigoid antigen by immunoprecipitation.
    Ebihara T; Hashimoto T; Kudoh J; Gamou S; Shimizu N; Nishikawa T
    J Invest Dermatol; 1993 Feb; 100(2):176-9. PubMed ID: 8429239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 230-kD basic protein is the major bullous pemphigoid antigen.
    Mueller S; Klaus-Kovtun V; Stanley JR
    J Invest Dermatol; 1989 Jan; 92(1):33-8. PubMed ID: 2462597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hemidesmosomal transmembrane collagenous molecule, the 180-kDa bullous pemphigoid antigen (BPA II), is phosphorylated with 12-O-tetradecanoylphorbol-13-acetate in a human squamous cell carcinoma cell line (DJM-1).
    Kitajima Y; Owada MK; Fujisawa Y; Seishima M; Yaoita H; Hirako Y; Owaribe K
    Epithelial Cell Biol; 1995; 4(2):70-5. PubMed ID: 8688920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.
    Labib RS; Anhalt GJ; Patel HP; Mutasim DF; Diaz LA
    J Immunol; 1986 Feb; 136(4):1231-5. PubMed ID: 2418109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Western blot analysis of the antigen in pemphigoid gestationis.
    Kelly SE; Bhogal BS; Wojnarowska F; Whitehead P; Leigh IM; Black MM
    Br J Dermatol; 1990 Apr; 122(4):445-9. PubMed ID: 2186774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigoid nodularis: a case with 230 kDa hemidesmosomes antigen associated with bullous pemphigoid antigen.
    Tamada Y; Yokochi K; Oshitani Y; Nitta Y; Ikeya T; Hara K; Owaribe K
    J Dermatol; 1995 Mar; 22(3):201-4. PubMed ID: 7738277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plectin, an unusual target antigen in bullous pemphigoid.
    Laffitte E; Favre B; Fontao L; Riou S; Jaunin F; Tamm K; Saurat JH; Borradori L
    Br J Dermatol; 2001 Jan; 144(1):136-8. PubMed ID: 11167694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative expression of bullous pemphigoid antigens in normal human epidermis and cultured keratinocytes.
    Su H; Reano A; Viac J; Thivolet J
    Clin Immunol Immunopathol; 1989 Jun; 51(3):406-13. PubMed ID: 2656012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectronmicroscopy.
    Bédane C; Prost C; Bernard P; Catanzano G; Bonnetblanc JM; Dubertret L
    J Invest Dermatol; 1991 Jul; 97(1):3-9. PubMed ID: 2056190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule.
    Hamada T; Nagata Y; Tomita M; Salmhofer W; Hashimoto T
    Exp Dermatol; 2001 Aug; 10(4):256-63. PubMed ID: 11493314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins.
    Nakatani C; Muramatsu T; Shirai T
    Br J Dermatol; 1998 Sep; 139(3):365-70. PubMed ID: 9767278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular heterogeneity of the bullous pemphigoid antigen as detected by immunoblotting].
    Izumi H; Hosokawa H
    Nihon Hifuka Gakkai Zasshi; 1989 Jul; 99(8):871-5. PubMed ID: 2685419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
    Ghohestani RF; Claudy A
    Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel bullous pemphigoid antigen (BP125) located in the deeper layers of the basement membrane zone.
    Gao SQ; Bystryn JC
    Arch Dermatol; 1994 Jul; 130(7):873-8. PubMed ID: 8024275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens.
    Robledo MA; Kim SC; Korman NJ; Stanley JR; Labib RS; Futamura S; Anhalt GJ
    J Invest Dermatol; 1990 Jun; 94(6):793-7. PubMed ID: 2192002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of intravenous immunoglobulin therapy on autoantibody titres to BP Ag1 and BP Ag2 in patients with bullous pemphigoid.
    Sami N; Ali S; Bhol KC; Ahmed AR
    J Eur Acad Dermatol Venereol; 2003 Nov; 17(6):641-5. PubMed ID: 14761129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of hemidesmosomes in vitro by a transformed rat bladder cell line.
    Riddelle KS; Green KJ; Jones JC
    J Cell Biol; 1991 Jan; 112(1):159-68. PubMed ID: 1986003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen.
    Matsumura K; Amagai M; Nishikawa T; Hashimoto T
    Arch Dermatol Res; 1996 Aug; 288(9):507-9. PubMed ID: 8874743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of bullous pemphigoid antibodies by use of recombinant bullous pemphigoid antigen proteins.
    Tanaka M; Hashimoto T; Amagai M; Shimizu N; Ikeguchi N; Tsubata T; Hasegawa A; Miki K; Nishikawa T
    J Invest Dermatol; 1991 Oct; 97(4):725-8. PubMed ID: 1940445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate hypersensitivity phenomena in bullous pemphigoid: critical concepts.
    Bowszyc-Dmochowska M; Dmochowski M
    J Med; 2002; 33(1-4):189-98. PubMed ID: 12939118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.